Limulus Bio

Limulus Bio is a medical device-focused biocompatibility and toxicology services company that supports clients across biological evaluation, toxicological risk assessment, material selection, and regulatory interactions. The company serves the MedTech market rather than operating as a therapeutics developer, and it also provides internal and external training as well as industry conferences in biocompatibility and toxicology. Limulus Bio was founded in Sweden and built a presence in both Europe and the United States. In October 2022, the company was acquired by Veranex and is now part of Veranex’s broader MedTech services offering. Its work centers on helping medical device companies navigate standards such as ISO 10993 and related biological safety requirements.